| Literature DB >> 36122239 |
Olivia M Manley1, Han N Phan1, Allison K Stewart2,3, Dontae A Mosley1, Shan Xue4, Lide Cha2, Hongxia Bai2,3, Veda C Lightfoot5, Pierson A Rucker1, Leonard Collins3, Taufika Islam Williams3, Wei-Chen Chang2, Yisong Guo4, Thomas M Makris1,2.
Abstract
Chlamydia protein associating with death domains (CADD) is involved in the biosynthesis of para-aminobenzoate (pABA), an essential component of the folate cofactor that is required for the survival and proliferation of the human pathogen Chlamydia trachomatis. The pathway used by Chlamydiae for pABA synthesis differs from the canonical multi-enzyme pathway used by most bacteria that relies on chorismate as a metabolic precursor. Rather, recent work showed pABA formation by CADD derives from l-tyrosine. As a member of the emerging superfamily of heme oxygenase-like diiron oxidases (HDOs), CADD was proposed to use a diiron cofactor for catalysis. However, we report maximal pABA formation by CADD occurs upon the addition of both iron and manganese, which implicates a heterobimetallic Fe:Mn cluster is the catalytically active form. Isotopic labeling experiments and proteomics studies show that CADD generates pABA from a protein-derived tyrosine (Tyr27), a residue that is ∼14 Å from the dimetal site. We propose that this self-sacrificial reaction occurs through O2 activation by a probable Fe:Mn cluster through a radical relay mechanism that connects to the "substrate" Tyr, followed by amination and direct oxygen insertion. These results provide the molecular basis for pABA formation in C. trachomatis, which will inform the design of novel therapeutics.Entities:
Keywords: folate biosynthesis; heterobinuclear cluster; radical transfer; spectroscopy
Mesh:
Substances:
Year: 2022 PMID: 36122239 PMCID: PMC9522330 DOI: 10.1073/pnas.2210908119
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 12.779